Indication
Nontuberculous
7 clinical trials
11 products
1 drug
Clinical trial
Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease. Two Doses Phase II, Single Center, Open-label TrialStatus: Terminated, Estimated PCD: 2023-12-31
Product
OmadacyclineProduct
PlaceboClinical trial
A Ph. 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, & Tolerability of Oral Omadacycline in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus ComplexStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Product
Interleukin-7Product
ALISProduct
AzithromycinProduct
EthambutolClinical trial
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Validate Patient-Reported Outcome Instruments in Adult Subjects With Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium AviStatus: Completed, Estimated PCD: 2023-05-09
Product
ELCClinical trial
An Open-label, Non-controlled, Multicenter, Pilot Trial, Using Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial (NTM) InfectionStatus: Terminated, Estimated PCD: 2020-10-02
Product
MolgramostimClinical trial
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous MycobactStatus: Recruiting, Estimated PCD: 2023-08-21
Clinical trial
ICoN-1: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Clofazamine Inhalation Suspension When Added to Guideline-Based Therapy in Participants With Nontuberculous Mycobacterial InfectionStatus: Not yet recruiting, Estimated PCD: 2026-08-01
Product
ClofazimineDrug
VarlilumabClinical trial
An Open-label, Non-controlled, Multicentre, Pilot Clinical Trial of Inhaled Molgramostim in Subjects With Antibiotic-resistant Non-tuberculosis Mycobacterial (NTM) InfectionStatus: Completed, Estimated PCD: 2019-10-15
Product
Antimycobacterial regimen